DynaCirc CR Dosage
Generic name: ISRADIPINE 5mg
Dosage form: tablet, film coated, extended release
Medically reviewed by Drugs.com. Last updated on Jul 27, 2020.
The dosage of DYNACIRC CR Controlled Release Tablets should be individualized. The recommended initial dose of DYNACIRC CR is 5 mg once-daily as monotherapy or in combination with a thiazide diuretic. An antihypertensive response usually occurs within 2 hours, with the peak antihypertensive response occurring 8 to 10 hours post-dose; blood pressure reduction is maintained for at least 24 hours following drug administration. If necessary, the dose may be adjusted in increments of 5 mg at 2 to 4 week intervals up to a maximum dose of 20 mg/day. Adverse experiences are increased in frequency above 10 mg/day.
DYNACIRC CR Controlled Release Tablets should be swallowed whole and should not be bitten or divided.
The bioavailability (increased AUC) of immediate-release DYNACIRC is increased in elderly patients (older than 65 years of age), patients with hepatic functional impairment, and patients with mild renal impairment. Ordinarily, a starting dose of DYNACIRC CR 5 mg once-daily should be used in these patients.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about DynaCirc CR (isradipine)
- Side Effects
- During Pregnancy or Breastfeeding
- Drug Images
- Drug Interactions
- 1 Review
- Drug class: calcium channel blocking agents
Other brands: Dynacirc